An anti-herpes drug researchers were counting on to reduce susceptibility to HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States. infection doesn't offer any protection, according to results presented at the 15th annual Conference on Retroviruses and Opportunistic Infections this February.
In the study more than 3,000 participants with herpes simplex virus Herpes simplex virus
A virus that can cause fever and blistering on the skin, mucous membranes, or genitalia.
Mentioned in: Conjunctivitis
herpes simplex virus 2 were given either 400 milligrams of the anti-herpes medication acyclovir acyclovir /acy·clo·vir/ (a-si´klo-ver) a synthetic purine nucleoside with selective activity against herpes simplex virus; used as the base or the sodium salt in the treatment of genital and mucocutaneous herpesvirus infections. or a placebo twice daily. Results showed a 3.9% HIV incidence rate (75 cases) among participants who received acyclovir, compared to a 3.3% HIV incidence rate (64 cases) among the placebo group.
The research was considered particularly important because having herpes, one of the most common sexually transmitted diseases Sexually transmitted diseases
Infections that are acquired and transmitted by sexual contact. Although virtually any infection may be transmitted during intimate contact, the term sexually transmitted disease is restricted to conditions that are largely worldwide, almost triples a person's odds of acquiring HIV.